EMA has published its Regulatory Science Strategy to 2025 on 31 March 2020. The strategy provides a plan for advancing regulatory science over the next five years, covering both human and veterinary medicines. Read the document
Davy Chiodin, one of our programme committee members for the MRD multi-stakeholder workshop, said “The Cancer Drug Development Forum aims to help paint a realistic picture of what’s really needed from all parties for robust and global MRD validation plans.” Read the article
CDDF is launching a new initiative on Microbiomes!
Read more and join the first workshop in February 2019
Support the ECPC Personalised Medicine Awareness Month #PMAM18
This November, join the European Cancer Patient Coalition (ECPC) advocating for greater access to molecular testing in Europe. Just one test could change a patient’s treatment plan & help us in #CrackingTheCancerCode. Show your support for ECPC Personalised Medicine Awareness Month: http://ecpc.org/personalisedmedicine2018 #PMAM18
Read the discussion summary of the CDDF Multi-stakeholder workshop on Involving Patients In Oncology Drug Development (18-19 June 2019, Amsterdam)
The use of real-world data in cancer drug development
European Journal of Cancer (EJC), Volume 101, September 2018, Pages 69-76
The Current and Future Challenges of Personalised Cancer Therapy published in the Open Access Government Magazine: ‘Managing Director of The Cancer Drug Development Forum, Prof. H. Zwierzina reveals his opinions on the current and future challenges of personalised cancer therapy, including the need for biomarkers’
5th Immunotherapy of Cancer Conference (ITOC5), 19-21 March 2018, Berlin, Germany – Abstract Book
European Journal of Cancer (EJC), Volume 92, Supplement 1, S1-S26, March 2018
Read the summary of the CDDF 10th Alpine Conference
(26 – 28 February 2018, Innsbruck, Austria)
More CDDF publications? Click here !
FOLLOW US ON TWITTER !
Follow us on Twitter! cddf_eu
Follow the latest updates and join the discussion by using #cddf